Atlas Trials

Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance

Clinical trial NCT00219791 · COMPLETED

Trial details

NCT number
NCT00219791
Sponsor
BTG International Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neoplasms
Start date
2000-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.